- €16.65m
- €38.86m
- €43.13m
- 36
- 73
- 46
- 49
Annual balance sheet for Bio-UV SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 2.2 | 12.6 | 10.6 | 1.98 | 2.73 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4.39 | 4.47 | 6.94 | 7.34 | 7.89 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 16.1 | 30.5 | 35 | 31 | 27.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.83 | 2.83 | 2.88 | 3.08 | 5.22 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 36.3 | 51.9 | 81.1 | 74.1 | 71.4 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8.35 | 9.41 | 19 | 18.8 | 19.4 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 20 | 21.5 | 50.5 | 41.7 | 39.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 16.3 | 30.4 | 30.7 | 32.4 | 32.2 |
Total Liabilities & Shareholders' Equity | 36.3 | 51.9 | 81.1 | 74.1 | 71.4 |
Total Common Shares Outstanding |